aR-6,7-Dihydro-6-(10-hydroxyethyl)-6-methyl-5H-dibenzo[a,c]cycloheptene-1,2,3,9,10,11-hexaol

ID: ALA1089510

PubChem CID: 46866296

Max Phase: Preclinical

Molecular Formula: C18H20O7

Molecular Weight: 348.35

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(O)C1(C)Cc2cc(O)c(O)c(O)c2-c2c(cc(O)c(O)c2O)C1

Standard InChI:  InChI=1S/C18H20O7/c1-7(19)18(2)5-8-3-10(20)14(22)16(24)12(8)13-9(6-18)4-11(21)15(23)17(13)25/h3-4,7,19-25H,5-6H2,1-2H3

Standard InChI Key:  BOXWNEZQGRBMFD-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
    4.9111   -7.1583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9099   -7.9857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6247   -8.3985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3412   -7.9852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3383   -7.1547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6229   -6.7455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6264   -9.2213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9102   -9.6331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9097  -10.4573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6246  -10.8708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3415  -10.4540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3385   -9.6312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6205   -5.9205    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1965   -6.7460    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1951   -8.3976    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1963   -9.2196    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1949  -10.8693    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6255  -11.6958    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0583   -8.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1542   -9.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3417   -8.7333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9250   -8.1458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7226   -8.3565    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7086   -7.3497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9250   -9.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  3  7  1  0
  6  1  1  0
  6 13  1  0
  1  2  2  0
  1 14  1  0
  3  4  2  0
  2 15  1  0
  7  8  2  0
  8 16  1  0
  9 17  1  0
  8  9  1  0
 10 18  1  0
  4  5  1  0
  4 19  1  0
  9 10  2  0
 12 20  1  0
  2  3  1  0
 19 21  1  0
 20 21  1  0
 10 11  1  0
 21 22  1  0
  5  6  2  0
 22 23  1  0
 11 12  2  0
 22 24  1  0
 12  7  1  0
 21 25  1  0
M  END

Associated Targets(Human)

ALOX5 Tclin Arachidonate 5-lipoxygenase (6568 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PTGS2 Cyclooxygenase-2 (1953 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Cyclooxygenase-1 (5266 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 348.35Molecular Weight (Monoisotopic): 348.1209AlogP: 2.07#Rotatable Bonds: 1
Polar Surface Area: 141.61Molecular Species: NEUTRALHBA: 7HBD: 7
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 7#RO5 Violations (Lipinski): 1
CX Acidic pKa: 8.14CX Basic pKa: CX LogP: 2.53CX LogD: 2.46
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.39Np Likeness Score: 1.21

References

1. Blunder M, Pferschy-Wenzig EM, Fabian WM, Hüfner A, Kunert O, Saf R, Schühly W, Bauer R..  (2010)  Derivatives of schisandrin with increased inhibitory potential on prostaglandin E(2) and leukotriene B(4) formation in vitro.,  18  (7): [PMID:20236826] [10.1016/j.bmc.2009.10.031]

Source